Changes in individual ownership, corporate or partnership structure, location, or blood-product handling activity shall be submitted on Form FDA-2830 (Blood Establishment Registration and Product Listing) as an amendment to registration within 5 days of such changes. Changes in the names of officers and directors of the corporations do not require such amendment but must be shown at time of annual registration.
Code of Federal Regulations
[40 FR 52788, Nov. 12, 1975, as amended at 66 FR 59158, Nov. 27, 2001]